Sudden Deafness Treatment Trial

NCT00097448 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

255

Enrollment

OTHER

Sponsor class

Conditions

Sudden Deafness

Interventions

DRUG: prednisone
DRUG: methylprednisolone sodium succinate

Sponsor

Massachusetts Eye and Ear Infirmary

Collaborators

[object Object]